Spotlight on Research

FRI Researcher interviewed

Michael Gordon
Dr. Michael Gordon

FRI is pleased to announce that Dr. Michael Gordon was recently interviewed by a reporter from WBAL-TV in Baltimore to discuss his 5-year National Institute on Drug Abuse (NIDA) funded study entitled "Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment," which uses Vivitrol in an effort to help pre-release inmates reduce opiate-taking behavior as they transition back to the community. Please click the link below to view the interview:

Spotlight on Research Archive